Business

Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events

STAFFORD, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today provided the following update on CEO interviews and corporate events. The following videos, which include CEO interviews, are now available on the Company’s website at the bottom of the Welcome

articleGreenwich Lifesciences, Inc.August 11, 20255/company/greenwich-lifesciences-inc/news/greenwich-lifesciences-provides-ceo-interviews-100000503
Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events

About this update from Greenwich Lifesciences, Inc.

[{"type":"image","alt":"Greenwich LifeSciences, Inc.","displaySize":"","headline":null,"caption":"Greenwich LifeSciences, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":123,"url":"https://media.zenfs.com/en/globenewswire.com/5236cbdf62d9160f7f17a269e6a93fa7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/CdB3UijgWjtUF2S9KALplg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE3MjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/5236cbdf62d9160f7f17a269e6a93fa7","width":300,"height":123}},"lazy":false},{"type":"text","content":"STAFFORD, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today provided the following update on CEO interviews and corporate events.","length":385,"tagName":"p"},{"type":"text","content":"The following videos, which include CEO interviews, are now available on the Company’s website at the bottom of the Welcome page: https://greenwichlifesciences.com/","length":164,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Jun 28, 2025 – Interview on Bloomberg TV (recorded April 2025)","length":62,"tagName":"p"}]},{"val":[{"type":"text","content":"Jun 4, 2025 – Live Fireside Chat with Research Analyst at Noble Virtual Conference","length":82,"tagName":"p"}]},{"val":[{"type":"text","content":"Apr 29, 2025 – Live Interview on Charles Schwab Network with Diane King Hall","length":76,"tagName":"p"}]},{"val":[{"type":"text","content":"Introductory Video ","length":18,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":238,"olType":false},{"type":"text","content":"The Company's recent prior events are listed below:","length":55,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Nov 19 - 21, 2024 – Jefferies London Healthcare Conference","length":58,"tagName":"p"}]},{"val":[{"type":"text","content":"Dec 10 - 13, 2024 – San Antonio Breast Cancer Symposium (SABCS) with Flamingo-01 Poster, Booth, & Conference Room ","length":117,"tagName":"p"}]},{"val":[{"type":"text","content":"Dec 19, 2024 – Annual Meeting of Stockholders","length":45,"tagName":"p"}]},{"val":[{"type":"text","content":"Feb 10 - 11, 2...

More updates from Greenwich Lifesciences, Inc.

The Companybiopharmaceutical companybreast cancerGreenwich